Cancers, Vol. 11, Pages 1054: Astragalus polysaccharide (PG2) Ameliorates Cancer Symptom Clusters, as well as Improves Quality of Life in Patients with Metastatic Disease, through Modulation of the Inflammatory Cascade Cancers doi: 10.3390/cancers11081054 Authors: Wen-Chien Huang Kuang-Tai Kuo Oluwaseun Adebayo Bamodu Yen-Kuang Lin Chun-Hua Wang Kang-Yun Lee Liang-Shun Wang Chi-Tai Yeh Jo-Ting Tsai Background: Improving patients’ quality of life (QoL)...
Thu Jul 25, 2019 03:00
Cancers, Vol. 11, Pages 1053: Context-Dependent Role of NF-κB Signaling in Primary Liver Cancer—from Tumor Development to Therapeutic Implications Cancers doi: 10.3390/cancers11081053 Authors: Carolin Czauderna Darko Castven Friederike L. Mahn Jens U. Marquardt Chronic inflammatory cell death is a major risk factor for the development of diverse cancers including liver cancer. Herein, disruption of the hepatic microenvironment as well as the immune cell composition are major...
Thu Jul 25, 2019 03:00
Cancers, Vol. 11, Pages 1052: Omics Approaches in Pancreatic Adenocarcinoma Cancers doi: 10.3390/cancers11081052 Authors: Iranzu González-Boja Antonio Viúdez Saioa Goñi Enrique Santamaria Estefania Carrasco-García Jairo Pérez-Sanz Irene Hernández-García Pablo Sala-Elarre Virginia Arrazubi Esther Oyaga-Iriarte Ruth Zárate Sara Arévalo Onintza Sayar Ruth Vera Joaquin Fernández-Irigoyen Pancreatic ductal adenocarcinoma, which represents 80% of pancreatic...
Thu Jul 25, 2019 03:00
Cancers, Vol. 11, Pages 1051: A Preliminary Investigation towards the Risk Stratification of Allogeneic Stem Cell Recipients with Respect to the Potential for Development of GVHD via Their Pre-Transplant Plasma Lipid and Metabolic Signature Cancers doi: 10.3390/cancers11081051 Authors: Daniel Contaifer Catherine H. Roberts Naren Gajenthra Kumar Ramesh Natarajan Bernard J. Fisher Kevin Leslie Jason Reed Amir A. Toor Dayanjan S. Wijesinghe The clinical outcome of...
Thu Jul 25, 2019 03:00
Cancers, Vol. 11, Pages 1050: PD-L1 Blockade by Atezolizumab Downregulates Signaling Pathways Associated with Tumor Growth, Metastasis, and Hypoxia in Human Triple Negative Breast Cancer Cancers doi: 10.3390/cancers11081050 Authors: Reem Saleh Rowaida Z. Taha Varun Sasidharan Nair Nehad M. Alajez Eyad Elkord Triple negative breast cancer (TNBC) is the most aggressive type of breast cancer, which shows resistance to common breast cancer therapies, as it lacks the expression...
Thu Jul 25, 2019 03:00
Cancers, Vol. 11, Pages 1046: A Retrospective Evaluation of Risk of Peripartum Cardiac Dysfunction in Survivors of Childhood, Adolescent and Young Adult Malignancies Cancers doi: 10.3390/cancers11081046 Authors: Chait-Rubinek Mariani Goroncy Herschtal Wheeler Dwyer Seymour Campbell Long-term survivors of childhood, adolescent and young adult (AYA) malignancies with past exposure to potentially cardiotoxic treatments are at risk of peripartum cardiac dysfunction....
Wed Jul 24, 2019 03:00
Cancers, Vol. 11, Pages 1048: Immunotherapies for the Treatment of Uveal Melanoma—History and Future
Cancers, Vol. 11, Pages 1048: Immunotherapies for the Treatment of Uveal Melanoma—History and Future Cancers doi: 10.3390/cancers11081048 Authors: Timo E. Schank Jessica C. Hassel Background: Uveal melanoma is the most common primary intraocular malignancy among adults. It is, nevertheless, a rare disease, with an incidence of approximately one case per 100,000 individuals per year in Europe. Approximately half of tumors will eventually metastasize, and the liver is the organ usually...
Wed Jul 24, 2019 03:00
Cancers, Vol. 11, Pages 1047: Long-Term Visual Outcomes for Small Uveal Melanoma Staged T1 Treated by Proton Beam Radiotherapy Cancers doi: 10.3390/cancers11081047 Authors: Adélaïde Toutée Martina Angi Sylvain Dureau Christine Lévy-Gabriel Livia Lumbroso-Le Rouic Rémi Dendale Laurence Desjardins Nathalie Cassoux There is increasing evidence of the survival benefit of treating uveal melanoma in an early stage, however it is important to discuss with the patient the...
Wed Jul 24, 2019 03:00
Cancers, Vol. 11, Pages 1045: Development of A New Mouse Model for Intrahepatic Cholangiocellular Carcinoma: Accelerating Functions of Pecam-1 Cancers doi: 10.3390/cancers11081045 Authors: Ihtzaz Ahmed Malik Gesa Malik Philipp Ströbel Jörg Wilting Due to the lack of suitable in-vivo models, the etiology of intrahepatic cholangiocellular carcinoma (ICC) is poorly understood. We previously showed the involvement of platelet endothelial cell adhesion molecule-1 (Pecam-1/CD31) in...
Wed Jul 24, 2019 03:00
Cancers, Vol. 11, Pages 1049: Dual Actions of Ketorolac in Metastatic Ovarian Cancer Cancers doi: 10.3390/cancers11081049 Authors: Laurie G. Hudson Linda S. Cook Martha M. Grimes Carolyn Y. Muller Sarah F. Adams Angela Wandinger-Ness Cytoreductive surgery and chemotherapy are cornerstones of ovarian cancer treatment, yet disease recurrence remains a significant clinical issue. Surgery can release cancer cells into the circulation, suppress anti-tumor immunity, and induce...
Wed Jul 24, 2019 03:00
Cancers, Vol. 11, Pages 1043: Synergic Interactions Between Hepatic Stellate Cells and Uveal Melanoma in Metastatic Growth Cancers doi: 10.3390/cancers11081043 Authors: Léo Piquet Louise Dewit Nathan Schoonjans Martial Millet Julie Bérubé Peter R. A. Gerges François Bordeleau Solange Landreville Uveal melanoma (UM) is a malignant intraocular tumor that spreads to the liver in half of the cases. Since hepatic cells could play a role in the therapeutic resistance of...
Wed Jul 24, 2019 03:00
Cancers, Vol. 11, Pages 1044: Rare Distant Metastatic Disease of Ovarian and Peritoneal Carcinomatosis: A Review of the Literature Cancers doi: 10.3390/cancers11081044 Authors: Nikolaos Thomakos Michail Diakosavvas Nikolaos Machairiotis Zacharias Fasoulakis Paul Zarogoulidis Alexandros Rodolakis Background: Although metastases of ovarian and peritoneal carcinomatosis are most commonly found within the peritoneal cavity, there is a number of other rare distant sites that...
Wed Jul 24, 2019 03:00
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου